Engineering death resistance in CHO cells for improved perfusion culture
Sign Up to like & getrecommendations! Published in 2022 at "mAbs"
DOI: 10.1080/19420862.2022.2083465
Abstract: ABSTRACT The reliable and cost-efficient manufacturing of monoclonal antibodies (mAbs) is essential to fulfil their ever-growing demand. Cell death in bioreactors reduces productivity and product quality, and is largely attributed to apoptosis. In perfusion bioreactors,… read more here.
Keywords: culture; cell; resistant cell; death ... See more keywords